Browsing Tag
Endocrinology
3 posts
Vertex (VRTX) to enter endocrine diseases with $10bn Crinetics acquisition, targets $5bn peak revenue by 2029
Vertex Pharmaceuticals to acquire Crinetics for $10 billion at 102% premium, largest deal in VRTX history. Read the full analysis.
The drug that could dethrone Voxzogo: FDA clears Ascendis Pharma’s navepegritide alfa for achondroplasia
FDA approves Ascendis Pharma's navepegritide alfa for achondroplasia, intensifying competition with BioMarin's Voxzogo. Read what this means for the rare disease market.
Smart insulin system improves glucose control for pregnant women with type 1 diabetes, according to ADA 2025 clinical trial findings
Smart insulin system shows improved glucose control in pregnancy with type 1 diabetes, per ADA 2025 trial; regulatory expansion expected. Read full details.